Transfer 10000 IU

Transfer 10000 Injection composition, such as Recombinant human erythropoietin alfa/epoetin alfa, is a medication classified as an erythropoiesis-stimulating agent (ESA). This drug is used to treat anemia resulting from chronic kidney disease (CKD), cancer chemotherapy, or HIV treatment with zidovudine. Additionally, it helps decrease the necessity for red blood cell transfusions in patients who are at a heightened risk of blood loss due to scheduled surgeries or other medical procedures.

Transfer injection is contraindicated in individuals with hypersensitivity to the drug or any of its ingredients, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. Caution is advised when administering this medication to patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. In children under 18, it should only be prescribed if the potential benefits surpass the risks. Older adults using this medication require careful monitoring for adverse effects. Prior to initiating treatment with Transfer 10000 injection, it is essential to consult with your healthcare provider regarding the associated risks and benefits.